Novel drug regimen can improve stem cell transplantation outcomes – Medical Xpress
Novel drug regimen can improve stem cell transplantation outcomesMedical XpressAdding bortezomib (Velcade) to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for patients receiving stem–cell transplants from mismatched and unrelated donors, according to researchers from Dana-Farber …Stem Cell Transplants can be improved by New Drug RegimenTopNews United States all 3 news articles …read … Continue reading
